Accès ouvert
2026
preprint
OpenAlex
Vidit Bhandarkar, Elen Torres-Mejia, Taylor Heim, Namita Nabar et autres
Lung adenocarcinoma, driven frequently by KRAS and p53 mutations, remains a leading cause of cancer mortality. Current state-of-the-art genetically engineered mouse models often rely on viral delivery of recombinases, such as Cre recombinase, to initiate transformation. However, viral particles can infect and …
us, ru
(code pays fourni par la source)
2026
article
OpenAlex
Tamara G. Dacoba, Simone A. Douglas-Green, Bhuvna Murthy, Alfonso D Restrepo et autres
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Pushkal Sharma, Heather R. Keys, Ryan Mansell, Jillian Stark et autres
us, fr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Kimberly R. Bennett, Yann S. Vanrobaeys, Tessy Teboh, Zakiya Smith et autres
Diffuse midline glioma (DMG) is a highly aggressive pediatric brain tumor that is difficult to treat because the blood-brain-tumor barrier (BBTB) prevents most drugs from reaching the tumor. A major obstacle for understanding this tumor-vascular niche is the lack of a perfusable …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Namita Nabar, Deeksha Kumaresh, Eduardo Nombera Bueno, Mae Pryor et autres
ABSTRACT Lipid nanoparticles (LNPs) have enabled the clinical translation of various nucleic acid cargos, including messenger RNA. Traditional LNP formulations contain a small proportion of lipids conjugated to poly(ethylene glycol), or PEG, which provides advantages of size control, stability, and extended circulation. …
us
(code pays fourni par la source)
2026
article
OpenAlex
Adam G. Berger, Chau Vo, Justin A. Kaskow, Shruti Rawal et autres
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Ivan Susin Pires, Ezra Gordon, Aidan Kindopp, Alexander D. Stoneman et autres
Engineering the surface chemistry of nanoparticles (NPs) via the electrostatic layer-by-layer (LbL) assembly approach is a viable strategy for developing targeted drug delivery vehicles. However, how assembly solution conditions and polymer molecular weight (MW) govern LbL-NP properties remains poorly understood. We investigated …
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Victoria F. Gomerdinger, Cassandra Parada, An Li, Aidan Kindopp et autres
Innate immune agonists are promising therapeutic agents to induce immune responses against cancer. However, these agents have been limited by toxicity associated with systemic accumulation and activity in off-target cells. In this work, a targeted nanoparticle (NP) platform to encapsulate and protect …
us
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Justin A. Kaskow, Altaf Bacchus, Victoria F. Gomerdinger, Adam G. Berger et autres
ABSTRACT Therapeutic activation of stimulator of interferon genes (STING) signaling shows promise as a method of inflaming the tumor microenvironment to generate an anti-cancer immune response. Frequent loss of STING expression in many human cancers renders small-molecule agonists ineffective in cancer cells. …
us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Justin A Kaskow, Julia Treese, Anita Gaenko, Victoria F. Gomerdinger et autres
Stimulator of interferon genes (STING) is a promising therapeutic target for cancer immunotherapy, but agonists are often rendered ineffective by the loss of STING expression in cancer cells. Here we engineer a multivalent peptide-polymer conjugate material that can easily be delivered to …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ivan Susin Pires, Margaret M. Billingsley, Ezra Gordon, Andrew J. Pickering et autres
Abstract Tumor‐targeted drug delivery enhances therapeutic efficacy while minimizing toxicity. Layer‐by‐layer nanoparticles (LbL‐NPs) coated with anionic polypeptides selectively bind to cancer cells, though the mechanisms have been unclear. Here, we integrated in silico and in vitro approaches—including gene expression analysis, receptor inhibition, …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ivan Susin Pires, Margaret M. Billingsley, Ezra Gordon, Andrew J. Pickering et autres
Tumor-targeted drug delivery enhances therapeutic efficacy while minimizing toxicity. Layer-by-layer nanoparticles (LbL-NPs) coated with anionic polypeptides selectively bind to cancer cells, though the mechanisms have been unclear. Here, we integrated in silico and in vitro approaches-including gene expression analysis, receptor inhibition, and …
us
(code pays fourni par la source)